Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.60
+0.15 (0.64%)
Mar 10, 2026, 2:12 PM CST
27.91%
Market Cap 1.70B
Revenue (ttm) 607.89M
Net Income (ttm) -83.60M
Shares Out 72.45M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 237,878
Average Volume 204,461
Open 24.20
Previous Close 23.45
Day's Range 23.20 - 24.20
52-Week Range 14.30 - 30.00
Beta 0.13
RSI 35.90
Earnings Date Apr 24, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements

News

There is no news available yet.